1. Home
  2. MOGO vs XCUR Comparison

MOGO vs XCUR Comparison

Compare MOGO & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mogo Inc.

MOGO

Mogo Inc.

HOLD

Current Price

$1.11

Market Cap

27.6M

Sector

N/A

ML Signal

HOLD

XCUR

Exicure Inc.

HOLD

Current Price

$6.11

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOGO
XCUR
Founded
2003
2011
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.6M
26.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MOGO
XCUR
Price
$1.11
$6.11
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
113.3K
2.1M
Earning Date
11-07-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.22
N/A
Revenue
$29,215,516.00
N/A
Revenue This Year
$63.05
N/A
Revenue Next Year
$5.58
N/A
P/E Ratio
$4.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$3.10
52 Week High
$3.83
$22.99

Technical Indicators

Market Signals
Indicator
MOGO
XCUR
Relative Strength Index (RSI) 34.67 55.97
Support Level $1.09 $5.63
Resistance Level $1.16 $6.32
Average True Range (ATR) 0.05 1.08
MACD 0.01 0.04
Stochastic Oscillator 12.47 34.77

Price Performance

Historical Comparison
MOGO
XCUR

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.

About XCUR Exicure Inc.

Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

Share on Social Networks: